News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,699 Results
Type
Article (45531)
Company Profile (312)
Press Release (685856)
Multimedia
Podcasts (81)
Webinars (13)
Section
Business (212381)
Career Advice (2251)
Deals (36554)
Drug Delivery (104)
Drug Development (82843)
Employer Resources (177)
FDA (16836)
Job Trends (15431)
News (357648)
Policy (33730)
Tag
Academia (2757)
Accelerated approval (6)
Adcomms (21)
Allergies (91)
Alliances (52653)
ALS (98)
Alzheimer's disease (1425)
Antibody-drug conjugate (ADC) (144)
Approvals (16824)
Artificial intelligence (292)
Autoimmune disease (24)
Automation (16)
Bankruptcy (367)
Best Places to Work (11968)
BIOSECURE Act (21)
Biosimilars (110)
Biotechnology (221)
Bladder cancer (81)
Brain cancer (28)
Breast cancer (294)
Cancer (2356)
Cardiovascular disease (188)
Career advice (1882)
Career pathing (31)
CAR-T (164)
Cell therapy (455)
Cervical cancer (20)
Clinical research (67244)
Collaboration (894)
Company closure (2)
Compensation (565)
Complete response letters (21)
COVID-19 (2723)
CRISPR (49)
C-suite (261)
Cystic fibrosis (105)
Data (2321)
Decentralized trials (2)
Denatured (32)
Depression (48)
Diabetes (280)
Diagnostics (6665)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (125)
Drug pricing (108)
Drug shortages (27)
Duchenne muscular dystrophy (100)
Earnings (88595)
Editorial (41)
Employer branding (22)
Employer resources (152)
Events (117481)
Executive appointments (762)
FDA (18212)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (799)
Gene editing (121)
Generative AI (26)
Gene therapy (333)
GLP-1 (759)
Government (4587)
Grass and pollen (5)
Guidances (136)
Healthcare (19629)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (125)
Indications (30)
Infectious disease (2875)
Inflammatory bowel disease (151)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (101)
Interviews (363)
IPO (16888)
IRA (43)
Job creations (3888)
Job search strategy (1601)
Kidney cancer (10)
Labor market (42)
Layoffs (496)
Leadership (19)
Legal (8207)
Liver cancer (79)
Lung cancer (330)
Lymphoma (158)
Machine learning (9)
Management (62)
Manufacturing (337)
MASH (72)
Medical device (14143)
Medtech (14148)
Mergers & acquisitions (20243)
Metabolic disorders (726)
Multiple sclerosis (84)
NASH (16)
Neurodegenerative disease (98)
Neuropsychiatric disorders (27)
Neuroscience (1989)
NextGen: Class of 2025 (6910)
Non-profit (4654)
Now hiring (40)
Obesity (385)
Opinion (237)
Ovarian cancer (78)
Pain (92)
Pancreatic cancer (89)
Parkinson's disease (152)
Partnered (21)
Patents (252)
Patient recruitment (116)
Peanut (49)
People (59683)
Pharmaceutical (69)
Pharmacy benefit managers (20)
Phase I (21097)
Phase II (29580)
Phase III (21994)
Pipeline (1330)
Policy (154)
Postmarket research (2610)
Preclinical (9035)
Press Release (71)
Prostate cancer (110)
Psychedelics (31)
Radiopharmaceuticals (266)
Rare diseases (395)
Real estate (6285)
Recruiting (66)
Regulatory (23102)
Reports (47)
Research institute (2495)
Resumes & cover letters (375)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (73)
Series A (139)
Series B (90)
Service/supplier (15)
Sickle cell disease (55)
Special edition (16)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3882)
State (2)
Stomach cancer (13)
Supply chain (70)
Tariffs (48)
The Weekly (47)
Vaccines (749)
Venture capitalists (43)
Weight loss (250)
Women's health (37)
Worklife (16)
Date
Today (228)
Last 7 days (919)
Last 30 days (3122)
Last 365 days (33553)
2025 (11884)
2024 (36302)
2023 (41231)
2022 (52512)
2021 (57117)
2020 (55784)
2019 (48621)
2018 (36623)
2017 (33755)
2016 (33374)
2015 (39536)
2014 (33112)
2013 (28161)
2012 (30431)
2011 (31029)
2010 (28952)
Location
Africa (798)
Alabama (54)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (40862)
Australia (6817)
California (6473)
Canada (2068)
China (547)
Colorado (278)
Connecticut (288)
Delaware (163)
Europe (89761)
Florida (946)
Georgia (221)
Idaho (60)
Illinois (571)
India (26)
Indiana (326)
Iowa (11)
Japan (174)
Kansas (109)
Kentucky (26)
Louisiana (12)
Maine (62)
Maryland (926)
Massachusetts (4854)
Michigan (245)
Minnesota (410)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (68)
New Hampshire (69)
New Jersey (1811)
New Mexico (28)
New York (1821)
North Carolina (1034)
North Dakota (9)
Northern California (2826)
Ohio (213)
Oklahoma (15)
Oregon (37)
Pennsylvania (1431)
Puerto Rico (14)
Rhode Island (34)
South America (1190)
South Carolina (25)
South Dakota (1)
Southern California (2435)
Tennessee (107)
Texas (958)
United States (24385)
Utah (195)
Virginia (155)
Washington D.C. (66)
Washington State (580)
West Virginia (3)
Wisconsin (59)
731,699 Results for "alr technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ALR Technologies Announces Canadian Launch Plans for the GluCurve Pet CGM
ALR Technologies SG Ltd., the diabetes management company, announces plans to launch the GluCurve Pet CGM in Canada during Q3 2023 with a direct to veterinarian clinic sales model through GluCurve.ca.
August 7, 2023
·
5 min read
ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
ALR Technologies SG Ltd. announces the patent application titled Method and System of Monitoring a Diabetes Treatment Plan has been granted in Singapore and has received notice of allowance in the United States.
September 28, 2023
·
5 min read
ALR Technologies Announces Second Generation GluCurve Pet CGM for Diabetic Cats and Dogs
ALR Technologies SG Ltd., the diabetes management company, announces the issuance of a purchase order for the first shipment of second generation CGM hardware used in the GluCurve Pet CGM.
June 1, 2023
·
4 min read
Press Releases
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
May 5, 2025
·
5 min read
ALR Technologies Announces Update to Singapore Migration Merger and GluCurve Pet CGM Commercialization
ALR Technologies Inc., the diabetes management company, is pleased to announce an update with respect to its migration to Singapore.
September 30, 2022
·
11 min read
Press Releases
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
April 16, 2025
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Press Releases
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 13, 2025
·
5 min read
Deals
ALR Technologies Announces Reincorporation Merger
ALR Technologies Inc. (“ALRT USA”) (OTCQB: ALRT), the diabetes management company, today announces that further to its release on June 1, 2021, ALRT USA has entered into an Agreement and Plan of Merger and Reorganization.
May 20, 2022
·
6 min read
1 of 73,170
Next
